NEW YORK – GATC Health and Liquid Biosciences said Wednesday that they are linking their bioinformatics platforms to accelerate biomarker and drug discovery for their pharmaceutical clients. The companies said that the partnership also will lower the cost of R&D and improve the safety and accuracy of clinical trials.